HIV-associated venous thromboembolism

Mediterranean Journal of Hematology and Infectious Diseases

Volumn 3, Issue 1, 2011, Pages

  Bibas, Michele ^a   Biava, Gianluigi ^a   Antinori, Andrea ^a  

^a NATIONAL INSTITUTE FOR INFECTIOUS DISEASES L SPALLANZANI   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84857786818     PISSN: None     EISSN: 20353006     Source Type: Journal    
DOI: 10.4084/MJHID.2011.030     Document Type: Article

References (118)

1. Global report: UNAIDS report on the global AIDS epidemic 2010. www.unaids.org (accessed 16 May 2011).
2. Palella FJ Jr, Delaney KM, Moorman AC, Loveless MO, Fuhrer J, Satten GA, Aschman DJ, Holmberg SD. Declining morbidity and mortality among patients with advanced human immunodeficiency virus infection. HIV Outpatient Study Investigators. N. Engl. L Med. 1998 338: 853-860.
3. Murphy EL, Collier AC, Kalish LA, Assmann SF, Para MF, Flanigan TP, Kumar PN, Mintz L, Wallach FR, Nemo GJ. Highly active antiretroviral therapy decreases mortality and morbidity in patients with advanced HIV disease. Ann Inter Med 2001 Jul 3 135(1): 17-26.
4. Mocroft A, Reiss P, Gasiorowski J, Ledergerber B, Kowalska J, Chiesi A, Gatell J, Rakhmanova A, Johnson M, Kirk O, Lundgren J. Serious fatal and non fatal non AIDS defining illnesses in Europe. J Acquir Immune Defic Syndr. 2010 Oct 1;55(2):262-70. doi:10.1097/QAI.0b013e3181e9be6b PMid:20700060
5. Naess IA, Christiansen SC, Romundstad P, Cannegieter SC, Rosendaal FR, Hammerstrøm J. Incidence and mortality of venous thromboembolism: a population based study. J Thromb Haemost. 2007;April 5(4):692-99 PMid: 17367492
6. Cohen AT, Tapson VF, Bergmann JF, Goldhaber SZ, Kakkar AK, Deslandes B, Huang W, Zayaruzny M, Emery L, Anderson FA Jr. Venous thromboembolism risk and prophylaxis in the acute hospital care setting (ENDORSE study): a multinational cross-sectional study. Lancet 2008;Feb 2 371: 387-394. doi:10.1016/S0140-6736(08)60202-0
7. Hirsh J, Guyatt G, Albers GW, Harrington R, Schünemann HJ, Antithrombotic and thrombolytic therapy: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition). Chest. 2008 Jun;133(6 Suppl):110S-112S. Erratum in: Chest. 2008 Aug;134(2):473 doi: 10.1378/chest.08-0652 PMid: 18574260
8. Jenkins RE, Peters BS, Pinching AJ. Thromboembolic disease in AIDS is associated with cytomegalovirus disease. AIDS 1991;Dec 5(12):1540-2. doi: 10.1097/00002030-199112000-00025 PMid: 1667576
9. Laing RBS, Brettle RP, Leen CLS. Venous thrombosis in HIV infection, Int J STD AIDS 1996; Mar-April 7(2):82-5. doi:10.1258/0956462961917410 PMid: 19244539
10. Howling SJ, Shaw PJ, Miller RF. Acute pulmonary embolism in patients with HIV disease. Sex Transm Infect 1999;75(1):25-9. doi:10.1136/sti.75.1.25 PMid: 10448338 PMCid: 1758180
11. George SL, Swindells S, Knudson R, Stapleton JT. Unexplained Thrombosis in HIV-infected Patients Receiving Protease Inhibitors: Report of Seven Cases. Am J Med 1999; Dec 107(6):624-6. doi:10.1016/S0002-9343(99)00296-X
12. Sullivan PS, Dworkin MS, Jones JL, Hooper WG. Epidemiology of thrombosis in HIV-infected individuals. AIDS 2000;14:321-4. doi:10.1097/00002030-200002180-00015PMid:10716509
13. Saber AA, Aboolian A, LaRaja RD, Baron H, Manna K. HIV/AIDS and the risk of deep vein thrombosis a study of 45 patients with lower extremity involvement. Am Surg 2001;67:645-7. PMid:11450780
14. Saif MW, Bona R, Greenberg B. AIDS and thrombosis: retrospective study of 131 HIV-infected patients. AIDS Patient Care STDS 2001:15(6):311-20. doi:10.1089/108729101750279687 PMid: 11445013
15. Copur AS, Smith PR, Gomez V, Bergman M, Homel P. HIV infection is a risk factor for venous thromboembolism. AIDS Patient Care STDS. 2002;16(5):205-9. doi:10.1089/10872910252972258 PMid: 12055028
16. Fultz SL, McGinnis KA, Skanderson M, Ragni MV, Justice AC.: Association of venous thromboembolism with human immunodeficiency virus and mortality in veterans. Am J Med 2004;Mar 15 116(6):420-3. doi:10.1016/j.amjmed.2003.10.011 PMid: 15006592
17. Ahonkhai AA, Gebo KA, Streiff MB, Moore RD, Segal JB. Venous thromboembolism in patients with HIV/AIDS: a case control study. J Acquir Immune Defic Syndr 2008; 48:310-314. doi:10.1097/QAI.0b013e318163bd70 PMid: 18197123 PMCid:2597553
18. Malek J., Rogers R., Kufera J., Hirson JM. Venous Thromboembolic disease in the HIV-infected patient. Am J Emerg Med. 2011 Mar;29(3):278-82. Epub 2010 Mar 26. doi:10.1016/j.ajem.2009.09.034 PMid:20825798
19. Crum-Cianflone NF, Weekes J, Bavaro M. Thromboses among HIV-infected patients during the highly active antiretroviral therapy era. AIDS Patient Care STDS. 2008 Oct;22(10):771-8. Review. doi:10.1089/apc.2008.0010 PMid: 18783326 PMCid:2753452
20. Rasmussen LD, Dybdal M, Gerstoft J, Kronborg G, Larsen CS, Pedersen C, Pedersen G, Jensen J, Pedersen L, Sørensen HT, Obel N. HIV and risk of venous thromboembolism: a Danish nationwide population-based cohort study. HIV Med. 2011 Apr;12(4):202-10. doi: 10.1111/j.1468-1293.2010.00869.x. Epub 2010 Aug 18. doi:10.1111/j.1468-1293.2010.00869.x PMid:20726905
21. Goldhaber SZ. Risk Factors for Thromboembolism. JACC 56,1 2010 June 29 1-7 doi:10.1016/j.jacc.2010.01.057 PMid:20620709
22. Wilkerson WR, Sane DC. Aging and Thrombosis. Semin Thromb and haemost 2002; 28: 555-567. doi: 10.1055/s-2002-36700 PMid: 12536349
23. Jacobson MC, Debuze BJ, Aboulafia DM. Thrombotic complications in patients infected with HIV in the era of Highly active antiretroviral therapy: a case series. Clinc Infect Dis 2004;39:1214-22. doi:10.1086/424664 PMid: 15486847
24. Appay V, Rowland-jones SL. Premature ageing of the immune system: the cause of AIDS? Trends Immunol 2002;23:580-5. doi:10.1016/S1471-4906(02)02338-4
25. Deeks SG, Phillips AN, HIV infection, antiretroviral treatment, ageing, and non-AIDS related morbidity. BJM Jan:26.338.288-292
26. Kuller LH, Tracy R, Belloso W, De Wit S, Drummond F, Lane HC, Ledergerber B, Lundgren J, Neuhaus J, Nixon D, Paton NI, Neaton JD. Inflammatory and coagulation biomarkers and mortality in patients with HIV infection. PLoS Med 2008:Oct 21 5(10):e203.
27. Lillam AL. Cardiovascular and Thrombosis pathology associated with cocaine use. Hematol Oncol Clin North Am 1993:7:1143-51.PMid:8294312
28. Syed FF, Beeching NJ. Lower-limb deep-vein thrombosis in a general hospital:risk factors, outcome and the contribution of intravenous drug use. QJM 2005;98: 139-145. doi:10.1093/qjmed/hci020 PMid: 15655094
29. Lafeuillade A, Alessi MC, Poizot-Martin I, Dhiver C, Quilichini R, Aubert L, Gastaut JA, Juhan-Vague I. Protein S deficiency and HIV infection. N Engl J Med 1991;324(17):1220. doi:10.1056/NEJM199104253241717
30. Lafeuillade A, Alessi MC, Poizot-Martin I, Boyer-Neumann C, Zandotti C, Quilichini R, Aubert L, Tamalet C, Juhan-Vague I, Gastaut JA. Endothelial cell dysfunction in HIV infection. J Acquir Immune Defic Syndr 1992;5(2): 484-489. PMid: 1532830
31. Majluf-Cruz A, Silva-Estrada M, Sánchez-Barboza R, Montiel-Manzano G, Treviño-Pérez S, Santoscoy-Gómez M, de Chávez-Ochoa AR, Corona-de la Peña N, Nieto-Cisneros L. Venous Thrombosis among patients with AIDS. Clin Appl Thromb Hemost 2004;Jan 10(1):19-25. doi:10.1177/107602960401000104 PMid: 14979401
32. Lijfering WM, Ten Kate MK, Sprenger HG, Van der Meer J.: Absolute risk of venous and arterial thrombosis in HIV-infected patients and effects of combination antiretroviral therapy. J Thromb Haemost 2006;4:1928-30. doi:10.1111/j.1538-7836.2006.02047.x PMid:16961600
33. Anderson J.A.M., Weitz J.I., Hypercoagulable States. Clin Chest Med 31 (2010) 659-673 doi:10.1016/j.ccm.2010.07.004 PMid:21047574
34. Sorice M, Griggi T, Arcieri P, Circella A, d'Agostino F, Ranieri M, Modrzewska R, Lenti L, Mariani G. The role of Anticardiolipin and anti-Protein S Antibodies. Thromb Res 1994; Feb 15 73(3-4):165-75. doi:10.1016/0049-3848(94)90095-7
35. Hooper WC, Phillips DJ, Ribeiro MJ, Benson JM, George VG, Ades EW, Evatt BL. Tumor Necrosis Factor-alfa downregulates Protein S secretion in Human Microvascular and Umbelical Vein Endothelial Cells but not in the HepG-2 Hepatoma Cell Line. Blood 1994:Jul 15 84(2):483-9.
36. De Larranaga GF., Forastiero RR., Carreras LO., Alonso BS. Different types of antiphospholipid antibodies in AIDS.: A comparison with syphilis and the antiphospholipid syndrome. Thromb Res 1999 Oct 1;96 (1) 19-25. doi:10.1016/S0049-3848(99)00059-6
37. Feffer SE, Fox RL, Orsen MM, Harajai KJ., Glatt AE. Thrombotic tendencies and correlation with clinical status in patients infected with HIV. South Med J 1995;88(11):1126-1130. doi: 10.1097/00007611-199511000-00008 PMid:7481983
38. Demers C, Ginsberg JS, Hirsh J, Henderson P, Blajchman MA. Thrombosis in AT III deficiency persons. Report of a large kindred and literature review. Ann Inter MeD 1992:116: 754-761.
39. Flinn WR., McDaniel MD, Yao JS. Antithrombin III deficiency as a reflection of dynamic protein metabolism in patients undergoing vascular reconstruction. J Vasc Surgery 1984;1 25 888-895.
40. Espinosa G., Cervera R. Antiphospholipid syndrome: frequency, main cause and risk factors of mortality. Nat Rev Rheaumatol 6,296-300 2010. doi:10.1038/nrrheum.2010.47 PMid:20386563
41. Sene D., Piette JC, Cacoub P. Antiphospholipid antibodies, antiphospholipid syndrome and infections. Autoimmune Rev 2008;7:272-7 doi:10.1016/j.autrev.2007.10.001 PMid:18295729
42. Galrão L, Brites C, Atta ML, Atta A, Lima I, Gonzalez F, Magalhães F, Santiago M. Antiphospholipid antibodies in HIVpositive patients. Clin Rheumatol. 2007 Nov;26(11): 1825-30. Epub 2007 Feb 28. doi:10.1007/s10067-007-0581-6 PMid: 17332976
43. Palomo I, Alarcón M, Sepulveda C, Pereira J, Espinola R, Pierangeli S. Prevalence of antiphospholipid and antiplatelet antibodies in human immnunodeficiency virus(HIV)-infected Chilean Patients. J Clin Lab Anal 2003:17(6)209-15 doi:10.1002/jcla.10093 PMid: 14614742
44. Leder AN, Flansbaum B., Zandman-Goddard G., Asherson R, ShoenfeldY. Antiphospolipid syndrome induced by HIV. Lupus 2001;10:370-4. doi:10.1191/096120301669209574 PMid: 11403270
45. Uthman IW, Gharavi AE. Viral infections and antiphospholipid antibodies. Semin Arthritis Rheum 2002;31:256-63 doi: 10.1053/sarh.2002.28303 PMid: 11836658
46. Shahnaz S., Parikh G, Opran A. Antiphospholipid antibody syndrome manifesting as a deep venous thrombosis and pulmonary embolism in a patient with HIV. Am J Med Sci. 2004; 327:231-2 doi:10.1097/00000441-200404000-00010 PMid: 15084920
47. Funderburg NT, Mayne E, Sieg SF, Asaad R, Jiang W, Kalinowska M, Luciano AA, Stevens W, Rodriguez B, Brenchley JM, Douek DC, Lederman MM. Increased tissue factor expression on circulating monocytes in chronic HIV infection: relationship to in vivo coagulation and immune activation. BLOOD 2010 14:115: 161-167.
48. Garcia F, Fumero E., Gatell JM. Immune modulators and treatment interruption. Curr Opin HIV/AIDS 2008;3(2):124-130
49. Morel O, Toti F, Hugel B, Bakouboula B, Camoin-Jau L, Dignat-George F, Freyssinet JM. Procoagulant microparticles: disrupting the vascular homeostasis equation. Arterioscler. Thromb. Vasc. Biol. 2006 26(12)2594-604. doi: 10.1161/01.ATV.0000246775.14471.26 PMid: 16990554
50. Mackman N., Tilley RE, Key Ns. Role of the extrinsic pathway of blood coagulation in hemostasis and thrombosis. Arterioscler. Thromb. Vasc. Biol. 2007 27(8): 1687-93 doi:10.1161/ATVBAHA.107.141911 PMid: 17556654
51. Eyal A., Velelr M. HIV and venous thrombotic events. S Afr J Surg. 2009;47(2) 54-56. PMid:19626781
52. Bernasconi E, Uhr M, Magenta L, Ranno A, Telenti A. Homocysteinemia in HIV-infected patients treated with highly active antiretroviral therapy. AIDS 2001;15:1081-1082. doi:10.1097/00002030-200105250-00027 PMid: 11400001
53. Guaraldi G, Ventura P, Garlassi E, Orlando G, Squillace N, Nardini G, Stentarelli C, Zona S, Marchini S, Moriondo V, Tebas P. Hyperhomocysteinemia inHIV-infected patients: determinants of variability and correlations with predictors of cardiovascular disease. HIV Medicine 2009 10, 28-34. doi:10.1111/j.1468-1293.2008.00649.x PMid: 19125962
54. Eichinger S, Stümpflen A, Hirschl M, Bialonczyk C, Herkner K, Stain M, Schneider B, Pabinger I, Lechner K, Kyrle PA. Hyperhomocysteinemia is a risk factor of recurrent venous thromboembolism. Thromb Haemost 1998; 80: 566-69. PMid:9798970
55. den Heijer M, Willems HP, Blom HJ, Gerrits WB, Cattaneo M, Eichinger S, Rosendaal FR, Bos GM. Homocysteine lowering by B vitamins and the secondary prevention of deep vein thrombosis and pulmonary embolism: a randomized, placebocontrolled, double-blind trial. Blood 2007; 109: 139-44. doi: 10.1182/blood-2006-04-014654 PMid:16960155
56. Kyrle PA, Rosendaal FR., Eichinger S.: Risk assessment for recurrent venous thrombosis. Lancet 2010:376:2032-39. doi:10.1016/S0140-6736(10)60962-2
57. Gresele P, Momi S., Migliacci R.: Endothelium, venous thromboembolism and ischemic cardiovascular events.: Thromb Haemost 2010;103:56-61. doi:10.1160/TH09-08-0562 PMid:20062938
58. Migliacci R, Becattini C, Pesavento R, Davi G, Vedovati MC, Guglielmini G, Falcinelli E, Ciabattoni G, Dalla Valle F, Prandoni P, Agnelli G, Gresele P. Endothelial dysfunction in patients with spontaneous venous thromboembolism. Haematologica 2007;92:812-818. doi: 10.3324/haematol. 10872 PMid: 17550854
59. Gresele P, Migliacci R, Vedovati MC, Ruffatti A, Becattini C, Facco M, Guglielmini G, Boscaro E, Mezzasoma AM, Momi S, Pengo V. Patients with primary antiphospholipid antibody syndrome and without associated vascular risk factors present a normal endothelial function. Thromb Res 2009; 123:444-451. doi:10.1016/j.thromres.2008.05.015 PMid: 18617225
60. Wakefield TW., Myers DD, Henke PK., Mechanism of venous thrombosis and resolution. Arterioscler Thromb Vasc Biol 2008;28:387-391 doi: 10.1161/ATVBAHA. 108.162289 PMid: 18296594
61. Pomerantz RJ, Kuritzkes DR, de la Monte SM, Rota TR, Baker AS, Albert D, Bor DH, Feldman EL, Schooley RT, Hirsch MS. Infection of the retina by human immunodeficiency virus type I. N Engl J Med 1987 317:1643-47. doi:10.1056/NEJM198712243172607 PMid:3479685
62. Solages A, Vita JA, Thornton DJ, Murray J, Heeren T, Craven DE, Horsburgh CR Jr. Endothelial function in HIV-infected persons. Clin Infect Dis 2006:42(9): 1325-1332. doi:10.1086/503261 PMid:16586393 PMCid:2737346
63. Chi D, Henry J, Kelley J, Thorpe R, Smith JK, Krishnaswamy G. The effects of HIV infection on endothelial function. Endothelium 2000;7:223-42.PMid:11201521
64. Musselwhite LW, Sheikh V, Norton TD, Rupert A, Porter BO, Penzak SR, Skinner J, Mican JM, Hadigan C, Sereti I. Markers of endothelial dysfunction, coagulation and tissue fibrosis independently predict venous thromboembolism in HIV. AIDS 2011, 25:787-795. doi:10.1097/QAD.0b013e3283453fcb PMid:21412059
65. Polgar J, Matuskova J, Wagner DD. The P-selectin, tissue factor, coagulation triad. J Thromb Haemost 2005; 3:1590-1596. doi:10.1111/j.1538-7836.2005.01373.x PMid: 16102023
66. Rectenwald JE, Myers DD Jr, Hawley AE, Longo C, Henke PK, Guire KE, Schmaier AH, Wakefield TW. D-dimer, P-selectin, and microparticles: novel markers to predict deep venous thrombosis. A pilot study. Thromb Haemost 2005; 94:1312-1317. PMid:16411411
67. Ross AC, Armentrout R, O'Riordan MA, Storer N, Rizk N, Harrill D, El Bejjani D, McComsey GA. Endothelial activation markers are linked to HIV status and are independent of antiretroviral therapy and Lipoatrophy. J Acquir Immune Defic Syndr 2008; 49(5): 499-506. doi:10.1097/QAI.0b013e318189a794 PMid: 18989230 PMCid:2778267
68. Schved JF, Gris JC, Arnaud A, Martinez P, Sanchez N, Wautier JL, Sarlat C. von Willebrand factor antigen, tissue-type plasminogen activator antigen, and risk of death in human immunodeficiency virus 1-related clinical disease: independent prognostic relevance of tissue-type plasminogen activator. J Lab Clin Med 1992;120:411-419. PMid: 1517688
69. Toulon P, Lamine M, Ledjev I, Guez T, Holleman ME, Sereni D, Sicard D. Heparin Cofactor II deficiency in patients infected with the Human Immunodeficiency Virus. Thromb Haemost 1993 70: 730-735. PMid:8128426
70. Rolinski B, Geier SA, Sadri I, Klauss V, Bogner JR, Ehrenreich H, Goebel FD. Endothelin-1 immunoreactivity in plasma is elevated in HIV-1 infected patients with retinal microangiopathic syndrome. Clin Invest 1994;72:288-293. doi:10.1007/BF00180042 PMid:8043976
71. Seigneur M, Constans J, Blann A, Renard M, Pellegrin JL, Amiral J, Boisseau M, Conri C. Soluble adhesion molecules and endothelial cell damage in HIV infected patients. Thromb Haemost 1997;77:646-649 PMid:9134636
72. Hadigan C, Meigs JB, Rabe J, D'Agostino RB, Wilson PW, Lipinska I, Tofler GH, Grinspoon SS. Increased PAI-1 and tPA antigen levels are reduced with metformin therapy in HIVinfected patients with fat redistribution and insulin resistance. J Clin Endocrinol Metab 2001;86:939-943. doi:10.1210/jc.86.2.939
73. Schecter AD, Berman AB, Yi L, Mosoian A, McManus CM, Berman JW, Klotman ME, Taubman MB. HIV envelope gp120 activates human arterial smooth muscle cells. Proc Natl Acad Sci USA 2001;98:10142-10147. doi: 10.1073/pnas. 181328798 PMid: 11504923 PMCid:56929
74. Sugerman RW, Church JA, Goldsmith JC, Ens GE. Acquired protein S deficiency in children infected with human immunodeficiency virus. Pediatr Infect Dis J 1996;15:106-111 doi:10.1097/00006454-199602000-00003 PMid:8822281
75. Klein SK, Slim EJ, de Kruif MD, Keller TT, ten Cate H, van Gorp EC, Brandjes DP. Is chronic HIV infection associated with venous thrombotic disease? A systematic review. Neth J Med 2005;63:129-36. PMid: 15869040
76. Karpatkin S, Nardi M, Green D. Platelet and coagulation defects associated with HIV-1-infection. Thromb Haemost 2002;88:389-401. PMid: 12353066
77. Pinilla J, Hill AR.: Thromboembolism associated with acquired immunodeficiency syndrome [letter]. Chest 1992;102:1634. doi:10.1378/chest.102.5.1634a
78. Kiser LK., Badowski ME.: Risk factors for venous thromboembolism in patients with Human Immunodeficiency Virus Infection. Pharmacotheraphy.2010;30(12):1292-1302 doi:10.1592/phco.30.12.1292 PMid:21114396
79. Baker JV, Neuhaus J, Duprez D., Changes in Inflammatory and Coagulation Biomarkers: A Randomized Comparison of Immediate versus Deferred Antiretroviral Therapy in Patients With HIV Infection. J Acquir Immune Defic Syndr 2011;56:36-43. doi:10.1097/QAI.0b013e3181f7f61a PMid:20930640
80. Abgueguen P, Delbos V, Chennebault JM, Payan C, Pichard E. Vascular thrombosis and acute cytomegalovirus infection in immunocompetent patients: Report of 2 cases and literature review. Clin Inf Dis 2003;36:E134-E139. doi: 10.1086/374664 PMid: 12766855
81. Lijfering WM, Sprenger HG, Son van WJ, Van Der Meer J. Mesenteric vein thrombosis associated with primary cytomegalovirus infection: A case report. Blood Coagul Fibrinolysis 2007;18:509-511. doi:10.1097/MBC.0b013e3281a3bef9
82. Abgueguen P, Delbos V, Ducancelle A, Jomaa S, Fanello S, Pichard E. Venous thrombosis in immunocompetent patients with acute cytomegalovirus infection: A complication that may be underestimated. Clin Microbiol Infect 2010;16:851-854. PMid: 19686279
83. Tichelaar VY, Sprenger HG, Mäkelburg AB.: Active cytomegalovirus infection in patients with acute venous thrombosis: A case-control study. Am J Hematol. 2011 Feb 11. doi: 10.1002/ajh.22006. [Epub ahead of print] doi:10.1002/ajh.22006 PMid:21509792
84. Justo D, Finn T, Atzmony L, Guy N, Steinvil A.: Thrombosis associated with acute cytomegalovirus infection: a meta-analysis. Eur J Intern Med. 2011 Apr;22(2): 195-9. Epub 2010 Dec 16.
85. Atzmony L, Halutz O, Avidor B, Finn T, Zimmerman O, Steinvil A, Zeltser D, Giladi M, Justo D. Incidence of cytomegalovirusassociated thrombosis and its risk factors: a case-control study. Thromb Res. 2010 Dec;126(6):e439-43.
86. Centers for Disease Control and Prevention.: Guidelines for prevention and treatment of opportunistic infections in HIV infected adults and adolescents. MMWR Recomm Rep 2009;58(RR-4): 1-207. PMCid:2821196
87. Mulder R, Tichelaar YI, Sprenger HG, Mulder AB, Lijfering WM.: Relationship between cytomegalovirus infection and procoagulant changes in human immunodeficiency virusinfected patients. Clin Microbiol Infect. 2010 Nov 4. [Epub ahead of print]
88. Aboulafia DM, Bundow D, Waide S, Bennet C, Kerr D.: Initial observations on the efficacy of highly active antiretroviral therapy in the treatment of HIV-associated autoimmune thrombocytopenia. Am J Med Sci 2000;320:117-23. doi:10.1097/00000441-200008000-00010 PMid: 10981487
89. Rosen MJ. Respirology.: Pulmonary complications of HIV infection.2008 Mar; 13(2): 181-90. Review.
90. Santiago MB., Cossermelli W., Tuma MF., Pinto MN., Oliveira RM.: Anticardiolipin antibodies in patients with infectious diseases. Clin. Rheumat., 8: 23-28, 1989. doi:10.1007/BF02031064 PMid:2501063
91. Cohen AJ, Philips TM, Kessler CM. Circulating coagulation inhibitors in the acquired immunodeficiency syndrome. Ann Intern Med 1986;104:175-80. PMid:3080933
92. Turken O, Kunter E, Sezer M, Solmazgul E, Cerrahoglu K, Bozkanat E, Ozturk A, Ilvan A. Haemostatic changes in active pulmonary tuberculosis. Int J Tuberc Lung Dis 2002 6(10):927-932. PMid: 12365581
93. White NW: Venous thrombosis and rifampicin. Lancet 1989.2:434-35.
94. Ambrosetti M, Ferrarese M, Codecasa LR, Besozzi G, Sarassi A, Viggiani P, Migliori GB. Incidence of Venous Thromboembolism in Tuberculosis Patients. Respiration 2006, 73:396. doi:10.1159/000091188 PMid: 16439829
95. Khorana AA. Connolly GC.: Assessing Risk of Venous Thromboembolism in the Patient With Cancer. J Clin Oncol 2009 27:4839-4847. doi: 10.1200/JCO.2009.22.3271 PMid: 19720906 PMCid:2764392
96. Scates SM. Diagnosis and treatment of cancer- related thrombosis. Hematol Oncol Clin North Am. 1992;6:1329-1339 PMid:1452515
97. Engels EA, Pfeiffer RM, Goedert JJ, Virgo P, McNeel TS, Scoppa SM, Biggar RJ; Trends in cancer risk among people with AIDS in the United States 1980-2002. AIDS. 2006;20(12):1645-1654. doi:10.1097/01.aids.0000238411.75324.59 PMid: 16868446
98. Engels EA, Biggar RJ, Hall HI, Cross H, Crutchfield A, Finch JL, Grigg R, Hylton T, Pawlish KS, McNeel TS, Goedert JJ. Cancer risk in people infected with human immunodeficiency virus in the United States. Int J Cancer. 2008;123(1): 187-194. doi:10.1002/ijc.23487 PMid: 18435450
99. Schneider E, Whitmore S, Glynn KM, Dominguez K, Mitsch A, McKenna MT. Revised surveillance case definitions for HIV infection among adults, adolescents, and children aged <18 months and for HIV infection and AIDS among children aged 18 months to <13 years-United States, 2008. MMWR Recomm Rep. 2008;57(RR-10): 1-12.
100. Shiels MS, Pfeiffer RM, Gail MH, Hall HI, Li J, Chaturvedi AK, Bhatia K, Uldrick TS, Yarchoan R, Goedert JJ, Engels EA. Cancer Burden in the HIV-Infected Population in the United States.: J Natl Cancer Inst. 2011 May 4;103(9):753-62. Epub 2011 Apr 11. doi:10.1093/jnci/djr076 PMid:21483021
101. Kaufmann T, Nisce LZ, Metroka C.: Thromboembolism in AIDS-related Kaposi's sarcoma. JAMA 1991;266:2834. doi:10.1001/jama.266.20.2834
102. Barbaro G. Cardiovascular manifestations of HIV infection. Circulation 2002;106:1420-5. doi:10.1161/01.CIR.0000031704.78200.59 PMid: 12221062
103. Lyonne L, Magimel C, Cormerais L, Trouillier S, Bocquier B, Zenut M, Jacomet C, Laurichesse H, Beytout J, Lesens O. Thromboembolic events at the time of highly active antiretroviral therapies against human immunodeficiency virus].Rev Med Interne. 2008 Feb;29(2):100-4. Epub 2007 Nov 26. French. doi:10.1016/j.revmed.2007.10.417 PMid: 18164785
104. Shen YM, Frenkel EP. Thrombosis and a hypercoagulable state in HIV-infected patients. Clin Appl Thromb Hemost. 2004 Jul;10(3):277-80. doi:10.1177/107602960401000311 PMid: 15247986
105. Fernández Sánchez C, Marín Gámez N, López Martínez G, Carbayo Gorriz C. Thrombophlebitis by megestrol acetate in patients with human immunodeficiency virus infection. Med Clin (Barc). 1998 Jun20;111(2):76-7.
106. Force L, Barrufet P, Herreras Z, Bolibar I. Deep venous thrombosis and megestrol in patients with HIV infection. AIDS. 1999 Jul 30;13(11):1425-6. doi: 10.1097/00002030-199907300-00031 PMid: 10449306
107. Nagaraja V, Terriquez JA, Gavini H, Jha L, Klotz SA. Pulmonary Embolism Mimicking pneumonia in HIV patient. 2010 Case Report Med. 2010;2010:394546. Epub 2010 Jun 14.
108. Narayanan TS, Narawane NM, Phadke AY, Abraham P.: Multiple abdominal venous thrombosis in HIV-seropositive patient. Indian J Gastroenterol 1998;17:105-106. PMid:9695393
109. Soentjens P, Ostyn B, Van Outryve S, Ysebaert D, Vekemans M, Colebunders R. Portal vein thrombosis in a patient with HIV treated with a protease inhibitor-containing regimen. Acta Clin Belg 2006;61:24-29. PMid:16673613
110. Heit JA, Kobbervig CE, James AH, Petterson TM, Bailey KR, Melton LJ.: Trends in the incidence of venous thromboembolism during pregnancy or postpartum: a 30-year population-based study. Ann Intern Med 2005; 143:697-706. PMid: 16287790
111. Pham PA, Flexner C.: Emerging antiretroviral drug interactions. J Antimicrob Chemother. 2011 Feb;66(2):235-9. Epub 2010 Dec 5. doi:10.1093/jac/dkq448 PMid:21131695
112. Holbrook AM, Pereira JA, Labiris R, McDonald H, Douketis JD, Crowther M, Wells PS. Systematic overview of warfarin and its drug and food interactions. Arch Intern Med. 2005;165:1095-1106. doi:10.1001/archinte.165.10.1095 PMid:15911722
113. Fulco PP, Zingone MM, Higginson RT. Possible antiretroviral therapy-warfarin drug interaction. Pharmacotherapy 2008;28:945-9. doi:10.1592/phco.28.7.945 PMid:18576910
114. Bonora S, Lanzafame M, D'Avolio A, Trentini L, Lattuada E, Concia E, Di Perri G. Drug interactions between warfarin and efavirenz or lopinavir-ritonavir in clinical treatment. Clin Infect Dis 2008;46:146-7. doi:10.1086/524086 PMid: 18171231
115. Gatti G, Alessandrini A, Camera M, Di Biagio A, Bassetti M, Rizzo F. Influence of indinavir and ritonavir on warfarin anticoagulant activity. AIDS 1998;12:825-6. PMid:9619821
116. Knoell KR, Young TM, Cousins ES. Potential interaction involving warfarin and ritonavir. Ann Pharmacother 1998;32:1299-302. doi:10.1345/aph.17456 PMid:9876810
117. Hughes CA, Freitas A, Miedzinski LJ. Interaction between lopinavir/ritonavir and warfarin. CMAJ 2007;177:357-9. doi:10.1503/cmaj.061284 PMid: 17698824 PMCid: 1942099
118. Thompson GR 3rd, Lawrence VA, Crawford GE. HIV infection increases the risk of heparin-induced thrombocytopenia. Clin Infect Dis. 2007 Nov 15;45(10):1393-6. Epub 2007 Oct 8. doi:10.1086/522761 PMid:17968841